Searched for
ANTIMICROBIAL RESISTANCE SOLUTIONS
Scientists found 3,000-year-old honey in Egyptian tombs, and it was still edibleAncient Egyptian honey, sealed in tombs for millennia, has sparked tales of enduring edibility. While direct evidence is scarce, the remark...- A new nanotech breakthrough could help heal dangerous wounds antibiotics can’t treatScientists are using nanomaterials to heal stubborn wounds that resist antibiotic treatment through a new era of smart wound care. These li...
- Science at scale: India’s journey from food security to global leadershipToday, India is the world’s largest producer of milk, pulses, and spices; the largest exporter of rice; and among the leading producers of ...
- This "stinky" kitchen staple beats mint mouthwash, scientists say; And the results will surprise youNew research suggests that garlic could be a highly effective natural mouthwash. Studies indicate that garlic extract can significantly red...
- IIT Madras develops low-cost chip-based device for rapid antibiotic susceptibility testingResearchers at IIT Madras have created a low-cost device for quick antibiotic testing. This device uses electrochemical signals to check ba...
- Artificial Intelligence designs two potential antibiotics to combat drug-Resistant Gonorrhoea and MRSAResearchers have used AI to design two promising antibiotics that are helpful in combating drug-resistant bacteria, including gonorrhoea an...
- Bharat Biotech, GSK join hands to develop vaccine for severe diarrhoeaBharat Biotech and GSK plc have partnered to develop a vaccine for Shigellosis, a severe bacterial diarrhea. The altSonflex1-2-3 vaccine ca...
- Superbug crisis: Antibiotic-resistant superbugs may kill 4 crore people worldwide, claims new studySuperbugs: Antimicrobial resistance (AMR) could claim over 39 million lives globally by 2050, warns a study in The Lancet. The report highl...
- Bharat Biotech inks pact with Alopexx for anti-microbial vaccineBharat Biotech has partnered with Alopexx, Inc. to co-develop and commercialize the anti-microbial vaccine AV0328 in India and other low-in...
- Cipla expects to commence supplies to US from China plant later this yearCipla plans to start supplying from its China facility to the US market by the second half of the current fiscal year, following USFDA appr...
- Antibiotic (mis)use needs proper regulationIndia consumes a high volume of broad-spectrum antibiotics - drugs that treat a wide range of common bacterial infections and should be use...
- New India-UK research to trial easy-to-use test to cut antibiotic resistanceDOSA2, as the latest phase is known, is coordinated by the University of Edinburgh and includes partners at the University of the Arts Lond...
- DSIR Recognition to Venus Remedies' in-house R&D UnitWith the renewal of recognition from DSIR and its ongoing efforts to combat antimicrobial resistance, Venus Remedies Limited solidifies its...
- Oxford University's new mega centre to combat global antibiotic resistanceThe university experts warn that it is arguably the greatest economic and healthcare challenge facing the world post-Covid and therefore th...
- C-CAMP announces winners of AMR Quest 2020The AMR Quest 2020, which was launched in February, focuses on nurturing exceptional innovative ideas and solutions in the AMR domain that ...
- C-CAMP to jointly work on antimicrobial resistance solutions with AMR GlobalC-CAMP, an initiative of the Dept of Biotechnology, Ministry of Science and Technology, and the prominent public private partnership organi...
- Health ministry moves to limit antibiotics in meatThe ministry has specified the maximum permissible limits of various antibiotics in meat products.
- Overuse of antibiotics in animals to worsen India’s AMR problem: StudyIndia is expected to see an 82% increase in consumption of antibiotics in “food animals” from 2,633 tons of antibiotics in 2013, showed a n...
- India urged to intensify research for multi-drug resistant TBNew Delhi, March 23 (IANS) As India continues to have 24 per cent of the world's total Tuberculosis (TB) burden, the Indian Society for Cli...
- Drug resistance rising; pharma companies must invest in R&D: Jim O'Neill, Goldman SachsWe need to either force or encourage pharma cos to think it is in their own long-term interest to start trying to devote more money into pr...
Load More
